Generic placeholder image

Mini-Reviews in Medicinal Chemistry

Editor-in-Chief

ISSN (Print): 1389-5575
ISSN (Online): 1875-5607

p38 Mitogen-Activated Protein Kinase (MAPK) in Rheumatoid Arthritis

Author(s): J. Westra and P. C. Limburg

Volume 6, Issue 8, 2006

Page: [867 - 874] Pages: 8

DOI: 10.2174/138955706777934982

Price: $65

Abstract

The importance of p38 MAPK inhibitors as new drug for rheumatoid arthritis is reflected by the large number of compounds that has been developed over the last years. In this review new insights such as non-stressful activation of p38 MAPK, and the role of p38 MAPK in regulation of NF-κB recruitment are also discussed.

Keywords: Rheumatoid arthritis, drug, p38 MAPK


Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy